MEF2C and leukemia: Since MEF2C is normally downregulated during the ETP stage, prolonged or enhanced MEF2C expression may cause supraphysiological IL-7R signaling and BCL2 expression that contributes to the arrest, survival, and enhanced growth of ETP cells resulting in leukemia.